Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.22.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 6,425 $ 8,137
Accounts receivable 234 269
Lease receivable, current portion 16,037 920
Inventory 28 123
Assets held for sale 1,100 2,633
Prepaid expenses and other current assets 310 356
Total current assets 24,134 12,438
Non-current assets    
Property and equipment, net 3,308 2,367
Intellectual property, net 550 640
Investment in LINICO 2,000 1,500
Lease receivable, non-current portion 0 15,528
Other assets 893 796
Total non-current assets 6,751 20,831
Total assets 30,885 33,269
Current liabilities    
Accounts payable 898 685
Accrued expenses 2,331 3,005
Lease liability, current portion 288 388
Total current liabilities 3,517 4,078
Building purchase deposit 1,250 1,328
Lease liability, non-current portion 434 330
Total liabilities 5,201 5,736
Commitments and contingencies
Stockholders’ equity    
Common stock; $0.001 par value; 200,000,000 shares authorized; 75,772,815 and 70,416,552 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 76 70
Additional paid-in capital 217,030 211,309
Accumulated deficit (191,422) (183,846)
Total stockholders’ equity 25,684 27,533
Total liabilities and stockholders’ equity $ 30,885 $ 33,269